{"entity":{"type":"insider","cik":"0001409232","url":"/insider/0001409232","json_url":"/insider/0001409232.json","name":"Kidron Miriam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2014-04-03","last":"2023-03-15","span_basis":"filed_date"},"name_variants":[{"name":"Kidron Miriam","source":"filing","n_filings":7,"first_seen":"2014-04-03","last_seen":"2023-03-15"}],"transactions":[{"id":8702269,"accession":"0001209191-23-018952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018952","line_url":"/filing/0001209191-23-018952#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":201000.0,"total_display":"201,000.00","total_whole":"201,000","shares_owned_after":201666.0,"shares_owned_after_display":"201,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":4199118,"accession":"0001213900-17-008213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-17-008213","line_url":"/filing/0001213900-17-008213#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89636.0,"shares_display":"89,636","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":761906.0,"total_display":"761,906.00","total_whole":"761,906","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-03","scope":"insider"},{"id":4819813,"accession":"0001178913-17-001170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-17-001170","line_url":"/filing/0001178913-17-001170#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Scientific Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52814.0,"shares_display":"52,814","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":334312.62,"total_display":"334,312.62","total_whole":"334,313","shares_owned_after":89636.0,"shares_owned_after_display":"89,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-19","scope":"insider"},{"id":8545077,"accession":"0001213900-15-009818","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-15-009818","line_url":"/filing/0001213900-15-009818#line-3","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24000.0,"shares_display":"24,000","price_per_share":8.6128,"price_display":"8.61","price_state":"stated","total_value":206707.2,"total_display":"206,707.20","total_whole":"206,707","shares_owned_after":142450.0,"shares_owned_after_display":"142,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-30","filed_date":"2015-12-31","scope":"insider"},{"id":8545073,"accession":"0001213900-15-009818","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-15-009818","line_url":"/filing/0001213900-15-009818#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":9.0785,"price_display":"9.08","price_state":"stated","total_value":136177.5,"total_display":"136,177.50","total_whole":"136,178","shares_owned_after":166450.0,"shares_owned_after_display":"166,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-29","filed_date":"2015-12-31","scope":"insider"},{"id":8545068,"accession":"0001213900-15-009818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-15-009818","line_url":"/filing/0001213900-15-009818#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":9.265,"price_display":"9.26","price_state":"stated","total_value":101915.0,"total_display":"101,915.00","total_whole":"101,915","shares_owned_after":181450.0,"shares_owned_after_display":"181,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-28","filed_date":"2015-12-31","scope":"insider"},{"id":6333518,"accession":"0001178913-14-002918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-002918","line_url":"/filing/0001178913-14-002918#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8699.0,"shares_display":"8,699","price_per_share":8.4379,"price_display":"8.44","price_state":"stated","total_value":73401.2921,"total_display":"73,401.29","total_whole":"73,401","shares_owned_after":102814.0,"shares_owned_after_display":"102,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-11","filed_date":"2014-09-12","scope":"insider"},{"id":6333515,"accession":"0001178913-14-002918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-002918","line_url":"/filing/0001178913-14-002918#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":8.4026,"price_display":"8.40","price_state":"stated","total_value":193259.8,"total_display":"193,259.80","total_whole":"193,260","shares_owned_after":111513.0,"shares_owned_after_display":"111,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-10","filed_date":"2014-09-12","scope":"insider"},{"id":7062649,"accession":"0001178913-14-002866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001178913-14-002866","line_url":"/filing/0001178913-14-002866#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8301.0,"shares_display":"8,301","price_per_share":9.4099,"price_display":"9.41","price_state":"stated","total_value":78111.5799,"total_display":"78,111.58","total_whole":"78,112","shares_owned_after":134513.0,"shares_owned_after_display":"134,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-04","filed_date":"2014-09-08","scope":"insider"},{"id":6903057,"accession":"0001178913-14-001206","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001178913-14-001206","line_url":"/filing/0001178913-14-001206#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001409232","owner_name":"Kidron Miriam","owner_display_name":"Kidron Miriam","owner_url":"/insider/0001409232","role":"Director, Officer (Chief Technology Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137300.0,"shares_display":"137,300","price_per_share":12.029,"price_display":"12.03","price_state":"stated","total_value":1651581.7,"total_display":"1,651,581.70","total_whole":"1,651,582","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001176309","name":"ORAMED PHARMACEUTICALS INC.","url":"/issuer/0001176309","role":"Director, Officer (Chief Scientific Officer)","n_filings":7,"first_seen":"2014-04-03","last_seen":"2023-03-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001409232","retrieved_at":"2026-08-24T09:30:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}